Filing Details
- Accession Number:
- 0001209191-17-047893
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-07 16:33:21
- Reporting Period:
- 2017-08-03
- Filing Date:
- 2017-08-07
- Accepted Time:
- 2017-08-07 16:33:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1642041 | Paul Trower | 1801 Augustine Cut-Off Wilmington DE 19803 | Principal Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-08-03 | 295 | $125.98 | 11,853 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2017-08-04 | 3,000 | $17.79 | 14,853 | No | 4 | M | Direct | |
| Commons Stock | Disposition | 2017-08-04 | 3,000 | $125.25 | 11,853 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2017-08-04 | 3,000 | $0.00 | 3,000 | $17.79 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 22,187 | 2019-01-18 | No | 4 | M | Direct |
Footnotes
- Represents shares withheld to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
- Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
- Represents weighted average sale price. Actual sale prices ranged from $123.99 - $126.13.
- This includes an 4,977 aggregate of shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- Beginning January 19, 2012, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years
Billionaire Hedge Funds
